These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28447476)

  • 21. Vaccination against tuberculosis.
    Martin C; Aguilo N; Gonzalo-Asensio J
    Enferm Infecc Microbiol Clin (Engl Ed); 2018 Dec; 36(10):648-656. PubMed ID: 29627126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TB vaccines in clinical development.
    Ginsberg AM; Ruhwald M; Mearns H; McShane H
    Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S16-20. PubMed ID: 27470538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates.
    Larsen MH; Biermann K; Chen B; Hsu T; Sambandamurthy VK; Lackner AA; Aye PP; Didier P; Huang D; Shao L; Wei H; Letvin NL; Frothingham R; Haynes BF; Chen ZW; Jacobs WR
    Vaccine; 2009 Jul; 27(34):4709-17. PubMed ID: 19500524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical assessment of a new live attenuated Mycobacterium tuberculosis Beijing-based vaccine for tuberculosis.
    Levillain F; Kim H; Woong Kwon K; Clark S; Cia F; Malaga W; Lanni F; Brodin P; Gicquel B; Guilhot C; Bancroft GJ; Williams A; Jae Shin S; Poquet Y; Neyrolles O
    Vaccine; 2020 Feb; 38(6):1416-1423. PubMed ID: 31862194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the immunogenicity and efficacy of BCG and MTBVAC vaccines using a natural transmission model of tuberculosis.
    Roy A; Tomé I; Romero B; Lorente-Leal V; Infantes-Lorenzo JA; Domínguez M; Martín C; Aguiló N; Puentes E; Rodríguez E; de Juan L; Risalde MA; Gortázar C; Domínguez L; Bezos J
    Vet Res; 2019 Oct; 50(1):82. PubMed ID: 31615555
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innovative clinical trial designs to rationalize TB vaccine development.
    Ellis RD; Hatherill M; Tait D; Snowden M; Churchyard G; Hanekom W; Evans T; Ginsberg AM
    Tuberculosis (Edinb); 2015 May; 95(3):352-7. PubMed ID: 25802031
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel approaches to preclinical research and TB vaccine development.
    Walker KB; Guo M; Guo Y; Poecheim J; Velmurugan K; Schrager LK
    Tuberculosis (Edinb); 2016 Aug; 99 Suppl 1():S12-5. PubMed ID: 27452413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative genomics of the Mycobacterium signaling architecture and implications for a novel live attenuated Tuberculosis vaccine.
    Zhou P; Xie J
    Hum Vaccin Immunother; 2014; 10(1):159-63. PubMed ID: 24013364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current efforts and future prospects in the development of live mycobacteria as vaccines.
    Ng TW; Saavedra-Ávila NA; Kennedy SC; Carreño LJ; Porcelli SA
    Expert Rev Vaccines; 2015; 14(11):1493-507. PubMed ID: 26366616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antituberculous vaccine development: a perspective for the endemic world.
    Verma I; Grover A
    Expert Rev Vaccines; 2009 Nov; 8(11):1547-53. PubMed ID: 19863247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is a new tuberculosis vaccine necessary and feasible? A Cuban opinion.
    Sierra VG
    Tuberculosis (Edinb); 2006; 86(3-4):169-78. PubMed ID: 16677860
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel tuberculosis vaccines on the horizon.
    Parida SK; Kaufmann SH
    Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why don't we have an effective tuberculosis vaccine yet?
    Davenne T; McShane H
    Expert Rev Vaccines; 2016 Aug; 15(8):1009-13. PubMed ID: 27010255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosis.
    Griffiths KL; Villarreal DO; Weiner DB; Khader SA
    Hum Vaccin Immunother; 2016 Oct; 12(10):2649-2653. PubMed ID: 27322875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberculosis vaccine development at a divide.
    Kaufmann SH
    Curr Opin Pulm Med; 2014 May; 20(3):294-300. PubMed ID: 24626237
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination Against Tuberculosis With Whole-Cell Mycobacterial Vaccines.
    Scriba TJ; Kaufmann SH; Henri Lambert P; Sanicas M; Martin C; Neyrolles O
    J Infect Dis; 2016 Sep; 214(5):659-64. PubMed ID: 27247343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Update on Tuberculosis Vaccines.
    Gopalaswamy R; Subbian S
    Methods Mol Biol; 2022; 2410():387-409. PubMed ID: 34914059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TB vaccines for the World.
    Glyn Hewinson R
    Tuberculosis (Edinb); 2005; 85(1-2):1-6. PubMed ID: 15687020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rational vaccine pipeline for tuberculosis.
    Brennan MJ; Stone MR; Evans T
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1566-73. PubMed ID: 23131253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.